HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

11th Edition of International Conference on
Dental Innovations and Technologies

March 19-21, 2026 | Singapore

Dental Stem Cells

Dental Stem Cells

Dental stem cells have emerged as a promising therapeutic entity for the treatment of various dental and related maxillofacial conditions. Dental stem cells (DSCs) are mesenchymal stem cells derived from the dental tissue, including the periodontal ligament, dental pulp, deciduous teeth, and their surrounding hard and soft tissue. DSCs are capable of self-renewal, unlimited expansion, and multipotent differentiation. The efficacy of DSCs for the treatment of a wide range of dental and maxillofacial conditions has been documented in various in vitro and in vivo studies. A key advantage of DSCs compared to other traditional stem cells is their ability to be displaced from the site of injury and migrate to the area of injury. This is beneficial as it enables accurate and focused delivery of the stem cells, thus providing an efficient and precise approach to treating damaged tissue. Furthermore, their use generally produces no immunomodulatory response, making them ideal for autologous transplantation. Due to their therapeutic potential, much research regarding DSCs has been conducted in recent years. DSCs have shown potential to regenerate bone structures of the mouth, such as alveolar bone, and dentin. DSCs have also been proven to stimulate cementoblast differentiation in vitro which could potentially lead to the development of new ways of treating periodontal diseases. DSCs also have potential for treating congenital orofacial clefting and for regenerating other dental and maxillofacial tissues such as periodontal ligament and dentin. In addition, to their therapeutic potential, many studies have also shown that DSCs have immunomodulatory properties which could be beneficial for various clinical applications. For instance, DSCs have the potential to play a role in tissue engineering for the regeneration and repair of soft and hard tissue. Due to their immunomodulatory properties, DSCs could be used as a therapeutic agent to treat orthopedic conditions, such as cartilage damage. In conclusion, the growing use of DSCs in dentistry has huge potential for treatments of multiple dental and other maxillofacial conditions. Studies have shown success in a wide range of therapeutic potential, which include regeneration of bone and dentin, modulation of immune responses and tissue engineering.  

Committee Members
Speaker at Dental Innovations and Technologies 2026 - David Geoffrey Gillam

David Geoffrey Gillam

Queen Mary University of London, United Kingdom
Speaker at Dental Innovations and Technologies 2026 - Zvi Loewy

Zvi Loewy

New York Medical College, United States
Speaker at Dental Innovations and Technologies 2026 - Khamis A Hassan

Khamis A Hassan

Global Dental Research Centre, Canada
Dental 2026 Speakers
Speaker at Dental Innovations and Technologies 2026 - Laurindo Moacir Sassi

Laurindo Moacir Sassi

Erasto Gaertner Hospital Cancer Center and Mackenzie Evangelical University Hospital, Brazil
Speaker at Dental Innovations and Technologies 2026 - Arnaldo Castellucci

Arnaldo Castellucci

Dr. Castellucci MD, DDS, Italy
Speaker at Dental Innovations and Technologies 2026 - Yasser Khaled

Yasser Khaled

Marquette University, United States
Speaker at Dental Innovations and Technologies 2026 - Eduardo Rubio

Eduardo Rubio

University of Buenos Aires, Argentina

Submit your abstract Today

Tubetube
Watsapp